Recall record at a glance
| Official record | F-0189-2021 |
|---|---|
| Category | Food Recalls |
| Classification | Class I |
| FDA record status | Terminated |
| Recalling firm | Treehouse Foods |
| Report date | Dec 23, 2020 |
| Recall initiation date | Dec 3, 2020 |
| Quantity | 511cs/100/1 oz cups |
| Location | Oak Brook, IL, United States |
Official product description
HOUSE RECIPE HONEY MUSTARD DRESSING & DIP NET WT 1 OZ.(28g) cup CONTAINS: EGGS DISTRIBUTED BY SYSCO CORPORATION, HOUSTON, TEXAS 77077 UPC 0 73473 05797 8
Why the product was recalled
The firm was notified via a consumer complaint that the product contains the Lite Honey Mustard instead of the regular Honey Mustard. The Lite Honey Mustard contains milk which is not listed on the label.
Distribution information
Product was shipped to one customer in TN
How to read the classification
FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Telephone.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.